Kenneth Shock, a 2026 Neuralink VOICE clinical trial participant, demonstrates how a brain-computer interface (BCI) allows him to communicate using his original voice despite ALS-induced speech loss. The device records neural signals related to speech and bypasses muscle connection issues. Nir Even Chen, Neuralink's BCI Applications Head, confirms the technology captures thousands of signals simultaneously, empowering patients like Kenneth to imagine sentences and have them spoken aloud, marking a significant innovation in assistive technology.
Kenneth Shock, a 2026 Neuralink VOICE clinical trial participant, demonstrates how a brain-computer interface (BCI) allows him to communicate using his original voice despite ALS-induced speech loss. The device records neural signals related to speech and bypasses muscle connection issues. Nir Even Chen, Neuralink's BCI Applications Head, confirms the technology captures thousands of signals simultaneously, empowering patients like Kenneth to imagine sentences and have them spoken aloud, marking a significant innovation in assistive technology.